| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide novel processes for regulating immune responses in mammalian subjects, e.g., humans, afflicted with diseases such as cancers, infections, e.g., viral infections, bacterial infections, or immune dysfunctions, especially auto-immune disorders, e.g., diabetes, Crohn's disease, chronic rheumatoid arthritis, arteriosclerosis and ulcerative colitis, more particular, relating to generation of elevated levels of an intermediary metabolite, e.g., lipids or conjugated biomolecules, e.g., glycolipids, lipoproteins and glycoproteins other than antibodies, cytokines or hormones. <P>SOLUTION: The treatment is carried out by introduction of the intermediary metabolite into the afflicted subject or by a reagent that when administrated leads to elevated levels. The treatment regimen is in vivo or ex vivo. <P>COPYRIGHT: (C)2011,JPO&INPIT |
